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ABSTRACT	  Mycoplasma	  gallisepticum	  (MG)	  is	  a	  member	  of	  the	  most	  important	  avian	  mycoplasmas,	  causing	  chronic	  respiratory	  disease	  in	  chickens	  and	  lead	  ing	  to	  important	  economic	  losses	  in	  the	  poultry	  in	  dustry.	  Recombinant	  technology	  represents	  a	  strategic	  approach	  used	  to	  achieve	  highly	  reliable	  and	  specific	  diagnostic	  tests	  in	  veterinary	  diseases	  control:	  in	  par	  ticular	  this	  aspect	  is	  crucial	  for	  confirming	  mycoplasma	  infection	  and	  for	  maintaining	  mycoplasma-­‐free	  breeder	  flocks.	  In	  this	  study,	  we	  identified	  a	  component	  of	  the	  pyruvate	  dehydrogenase	  dihydrolipoamide	  acetyltrans	  ferase	  (i.e.,	  E2)	  protein	  by	  2-­‐dimensional	  electrophore	  sis	  (2-­‐DE),	  characterized	  it	  in	  immunoblotting	  assays,	  and	  analyzed	  its	  recombinant	  (r-­‐E2)	  in	  a	  rec-­‐ELISA	  test.	  For	  full-­‐length	  protein	  expression	  in	  Escherichia	  coli	  (EC)	  a	  point	  mutation	  was	  introduced.	  A	  rab	  bit	  antiserum	  produced	  against	  r-­‐E2	  was	  tested	  in	  a	  Western	  Blot	  using	  different	  samples	  of	  Mycoplasma	  species.	  The	  results	  showed	  the	  applicability	  of	  site	  directed	  mutagenesis,	  with	  a	  good	  yield	  of	  the	  r-­‐E2	  after	  purification.	  Also,	  anti-­‐E2	  serum	  reacted	  with	  all	  the	  tested	  MG	  strains	  showing	  no	  cross	  reaction	  with	  other	  mycoplasmas.	  The	  developed	  E2	  ELISA	  test	  was	  capable	  of	  detecting	  MG	  antibodies	  in	  the	  sera	  examined.	  Those	  results	  demonstrate	  the	  anti	  genic	  stability	  of	  the	  E2	  protein	  which	  could	  repre	  sent	  a	  recombinant	  antigen	  with	  potential	  diagnostic	  applications.	  	  Key	  words:	  Mycoplasma	  gallisepticum,	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INTRODUCTION	  Mycoplasma	  gallisepticum	  (MG)	  is	  an	  important	  pathogen	  of	  poultry	  worldwide	  that	  represents	  consid	  erable	  economic	  losses	  to	  the	  poultry	  industry,	  causing	  chronic	  respiratory	  disease	  in	  chickens	  and	  turkeys,	  re	  duction	  in	  egg	  production	  and	  quality,	  poor	  hatchability	  and	  feed	  efficiency,	  and	  increase	  in	  mortality	  and	  car	  cass	  condemnations	  besides	  the	  medication	  costs.	  (Ley	  et	  al.,	  2009;	  Ghorashi	  et	  al.,	  2010).	  The	  genus	  Mycoplasma	  (class	  Mollicutes)	  has	  evolved	  by	  degenerative	  or	  reductive	  evolution,	  accompanied	  by	  significant	  loss	  of	  genomic	  sequences	  and	  progressive	  adaptation	  to	  their	  specific	  hosts.	  They	  are	  distinguish	  able	  from	  other	  bacteria	  by	  their	  minute	  size	  and	  lack	  of	  a	  cell	  wall,	  and	  because	  of	  that,	  the	  surface	  proteins	  (lipoproteins)	  anchored	  or	  embedded	  in	  the	  cell	  mem	  brane	  play	  a	  crucial	  role	  in	  the	  interactions	  between	  the	  mycoplasmas	  and	  their	  hosts	  (Benˇcina	  et	  al.,	  1994).	  In	  the	  absence	  of	  a	  cell	  wall,	  the	  surface	  of	  the	  my	  coplasma	  membrane	  constitutes	  a	  critical	  interface	  in	  the	  infectious	  process,	  mediating	  basic	  functions	  such	  as	  the	  transport	  of	  nutrients	  as	  well	  as	  more	  complex	  interactions	  with	  the	  host	  cells	  and	  the	  host	  immune	  defenses.	  
The	  chronic	  nature	  of	  Mycoplasma	  infections	  demon	  strates	  a	  failure	  of	  the	  host	  immune	  system	  to	  deal	  effectively	  with	  these	  organisms.	  The	  well-­‐documented	  antigenic	  variation	  of	  surface	  proteins	  is	  a	  major	  con	  tributor	  to	  the	  complexity	  in	  implementing	  efficient	  preventive	  control	  measures	  and	  accurate	  diagnostic	  tests.	  It	  also	  allows	  MG	  to	  evade	  the	  host’s	  immune	  re	  sponse	  through	  the	  generation	  of	  escape	  variants	  (Glew	  et	  al.,	  2000;	  Hudson	  et	  al.,	  2006;	  Citti	  et	  al.,	  2010)	  and	  may	  contribute	  to	  resistance	  versus	  antimicrobial	  therapy	  by	  intracellular	  invasion	  and	  survival	  within	  eukaryotic	  cells	  (Winner	  et	  al.,	  2000).	  The	  knowledge	  derived	  from	  studies	  of	  MG	  proteins	  undoubtedly	  has	  considerable	  potential	  for	  diagnos	  tic	  application.	  Since	  serological	  monitoring	  of	  poul	  try	  is	  used	  extensively	  as	  a	  first-­‐line	  diagnostic	  test	  and	  will	  continue	  to	  be	  performed	  on	  a	  large	  scale	  in	  the	  future,	  there	  will	  be	  an	  increasing	  need	  for	  well-­‐defined	  and	  characterized	  antigens	  to	  enable	  the	  development	  of	  efficacious	  and	  cost-­‐effective	  control	  measures(Benˇcinaetal.,1994).Thecurrentlyused	  tests,	  such	  as	  the	  commercial	  rapid	  serum	  agglutina	  tion	  (RSA)	  and	  ELISA,	  as	  well	  as	  hemagglutination	  inhibition	  (HI),	  have	  greatly	  contributed	  to	  the	  control	  of	  Mycoplasma	  infections,	  but	  previous	  work	  reported	  a	  lack	  of	  specificity,	  mainly	  due	  to	  the	  intrinsic	  ability	  of	  various	  Mycoplasma	  species	  to	  cross-­‐react	  (Bu	  ̈yu	  ̈ktanir	  et	  al.,	  2010).	  As	  a	  consequence,	  recombinant	  technology	  could	  sig	  nificantly	  help	  to	  alleviate	  drawbacks,	  allowing	  the	  pro	  duction	  of	  unlimited	  amounts	  of	  multiple	  and	  more	  specific	  antigens	  (Ben	  Abdelmoumen	  Mardassi	  et	  al.,	  2008)	  although	  identification	  of	  immunogenic	  antigens	  and	  genetic	  manipulations	  of	  mycoplasma	  in	  general	  are	  more	  laborious	  than	  any	  other	  prokaryotic	  genome	  as	  far	  as	  to	  successfully	  express	  MG	  proteins	  in	  heterolo	  gous	  systems	  such	  as	  Escherichia	  coli	  (EC),	  the	  TGA	  codons	  that	  encode	  tryptophan	  in	  MG	  genes	  and,	  at	  the	  same	  time,	  are	  used	  in	  EC	  as	  a	  stop	  codons,	  need	  to	  be	  replaced	  by	  the	  TGG	  codon,	  unless	  the	  protein	  would	  be	  produced	  in	  a	  truncated	  form	  (Rosati	  et	  al.,	  2000).	  Numerous	  studies	  have	  focused	  on	  immunogenic	  pro	  teins	  of	  MG,	  particularly	  those	  involved	  in	  hemagglu	  tination,	  haemadsorption,	  and	  cytadhesion	  (Milosevic	  Berlic	  et	  al.,	  2000).	  Among	  specific	  antigens	  charac	  terized	  so	  far,	  researchers	  have	  identified	  a	  large	  cell	  surface-­‐exposed	  lipoprotein	  (i.e.,	  pMGA)	  involved	  in	  haemagglutination	  and	  also	  pvpA,	  a	  putative	  variable	  adhesin.	  Both	  proteins	  present	  polymorphisms	  and	  size	  variation	  in	  different	  MG	  strains,	  as	  well	  as	  a	  phase	  variable	  expression	  (Markham	  et	  al.,	  1992;	  Boguslavsky	  et	  al.,	  2000;	  Liu	  et	  al.,	  2001).	  Considering	  the	  limited	  size	  of	  Mycoplasma	  genomes,	  the	  number	  of	  genes	  in	  volved	  in	  generating	  antigenic	  diversity	  on	  their	  cell	  sur	  face	  is	  surprisingly	  large	  (Razin	  et	  al.,	  1998).	  In	  previous	  works,	  a	  surface	  protein	  called	  P52	  was	  described	  and	  found	  to	  be	  similar	  to	  the	  dihy	  drolipoamide	  acetyltransferase	  (i.e.,	  E2)	  from	  several	  mollicutes	  (Jan	  et	  al.,	  1996,	  2001).	  This	  protein	  is	  a	  membrane-­‐associated	  component	  of	  the	  pyruvate	  dehy	  drogenase	  complex	  which	  has	  been	  shown	  to	  be	  required	  for	  MG	  in	  vivo	  growth	  and	  survival	  in	  the	  host.	  Also,	  antibodies	  directed	  against	  P52	  induced	  growth	  inhi	  bition	  of	  cells	  and	  activation	  of	  the	  complement	  sys	  tem.	  Partial	  characterization	  of	  P52	  protein	  was	  limited	  to	  amino	  terminal	  peptide	  sequencing	  and	  a	  full	  anti	  genic	  characterization	  may	  be	  required	  to	  evaluate	  its	  diagnostic	  potential.	  The	  availability	  of	  the	  full	  genome	  sequence	  of	  MG	  allows	  the	  application	  of	  an	  immune	  proteome-­‐based	  strategy	  to	  identify	  potential	  antigenic	  sites,	  useful	  to	  further	  improve	  current	  diagnostic	  tests.	  The	  aim	  of	  the	  present	  study	  was	  to	  detect,	  iden	  tify,	  and	  characterize	  novel	  MG	  immunogenic	  proteins.	  For	  that,	  the	  proteome	  of	  MG	  was	  resolved	  on	  2	  dimensional	  electrophoresis	  (2-­‐DE),	  blotted	  on	  mem	  brane,	  and	  probed	  against	  monospecific	  sera.	  Along	  with	  the	  known	  haemagglutinin	  precursor,	  a	  second	  im	  munostained	  protein	  was	  identified	  by	  matrix-­‐assisted	  laser	  desorption/ionization	  time-­‐of-­‐flight/time-­‐of-­‐flight	  (MALDI-­‐TOF/TOF)	  mass	  spectrometry	  as	  E2	  pro	  tein.	  The	  corresponding	  gene	  was	  amplified,	  mutage	  nized,	  and	  cloned	  in	  a	  prokaryotic	  expression	  vector.	  Preliminary	  antigenic	  characterization	  
of	  recombinant	  E2	  (r-­‐E2)	  suggests	  that	  this	  protein	  is	  well-­‐conserved	  among	  and	  specific	  within	  MG	  isolates,	  and	  may	  be	  considered	  for	  the	  development	  of	  a	  specific	  diagnostic	  assay.	  
MATERIALS	  AND	  METHODS	  
Two-­‐Dimensional	  Gel	  Electrophoresis	  of	  Fractionated	  Mycoplasma	  Cell	  Proteins	  Mycoplasma	  gallisepticum	  American	  Type	  Culture	  Collection	  (ATCC)	  Strain	  15302,	  cultured	  according	  to	  Kleven	  et	  al.	  (1998)	  was	  centrifuged	  at	  6,000	  rpm	  for	  10min	  at	  4◦C	  and	  the	  pellet	  was	  washed	  in	  a	  1X	  phosphate-­‐buffered	  saline	  (PBS)	  solution	  3	  times	  as	  described	  (Regula	  et	  al.,	  2000).	  One	  milliliter	  preheated	  sodium	  dodecyl	  sulfate	  (SDS)	  1.0%	  and	  10	  μL	  phenyl	  methylsulfonyl	  fluoride	  (PMSF),	  0.1M,	  were	  added	  to	  the	  bacterial	  pellet	  and	  boiled	  for	  3min.	  The	  sample	  was	  sonicated	  3	  times	  in	  ice	  and	  centrifuged	  at	  10,000	  rpm	  for	  10min.	  Supernatant	  was	  collected	  and	  the	  protein	  concentration	  was	  determined	  by	  using	  a	  DC	  protein	  assay	  quantification	  kit	  (Biorad,	  Hercules,	  CA)	  and	  purified	  using	  the	  2D	  clean	  up	  kit	  (GE	  Healthcare,	  Little	  Chalfont,	  UK).	  The	  sample	  was	  resuspended	  in	  a	  lysis	  buffer	  containing	  8	  M	  urea,2	  Mthiourea,	  2.5%	  3-­‐[(3-­‐cholamidopropyl)dimethylammonio]-­‐1	  propanesulfonate	  (CHAPS),	  1.0%	  IPG	  buffer	  and	  20	  mMdithiothreitol(DTT,GEHealthcare,Little	  Chalfont,	  UK).	  Strips	  over	  the	  pH	  range	  of	  4	  to	  7	  (11	  cm,	  Biorad)	  were	  subjected	  to	  isoelectricfocusing	  (IEF)	  using	  the	  following	  parameters:	  rehydration	  at	  50V	  for	  12h;	  running	  at	  500V	  for	  1h,	  1,000V	  for	  1h,	  8,000V	  for	  1h,	  1,000	  to	  8,000V	  for	  4h,	  and	  500	  V	  for	  2	  h.	  After	  isoelectric	  focusing	  the	  gel	  strips	  were	  equilibrated	  2×	  in	  a	  buffer	  containing	  7	  M	  urea,	  500mM	  Tris-­‐HCl	  pH	  6.8,	  2%	  SDS,	  and	  10%	  glycerol.	  In	  the	  first	  equilibration	  step	  2%	  DTT	  was	  added,	  and	  in	  the	  second	  2.5%	  iodoacetamide,	  and	  incubation	  was	  performed	  with	  15	  min	  each.	  Immediately	  following	  equilibration,	  the	  IEF	  strips	  were	  transferred	  onto	  a	  10%	  SDS-­‐polyacrylamide	  gel.	  Electrophoresis	  was	  carried	  out	  at	  170	  V	  for	  1	  h.	  All	  2D	  gel	  electrophoresis	  experiments	  were	  run	  in	  triplicate.	  On	  2	  gels,	  200	  μg	  proteins	  were	  loaded	  and	  visualized	  by	  Comassie	  Blue	  staining;	  the	  third	  gel	  was	  used	  to	  run	  50	  μg	  proteins	  and	  visualized	  by	  silver	  stain	  ing.	  All	  gel	  stains	  were	  made	  with	  MALDI-­‐compatible	  colorants.	  Proteins	  from	  one	  of	  the	  Comassie	  gels	  were	  elec	  tro	  transferred	  to	  nitrocellulose	  membranes	  for	  Western	  immunoblot	  analyses	  using	  a	  monospecific	  MG	  anti	  serum	  (Biovac,	  Beaucouz	  ́e,	  France)	  diluted	  at	  1/100.	  The	  secondary	  antibody	  used	  was	  anti-­‐chicken	  IgY,	  HRP	  conjugate	  (Sigma-­‐Aldrich,	  Milano,	  Italy)	  diluted	  at	  1/1,000	  (Bencina	  et	  al.,	  1994).	  After	  the	  immunoblot,	  the	  Comassie	  gel	  and	  the	  blotted	  membrane	  were	  com	  pared	  in	  order	  to	  detect	  immunoreactive	  proteins.	  
Protein	  Identification	  The	  spots	  selected	  by	  immunochemical	  analyses	  were	  subjected	  to	  MALDI–TOF/TOF	  mass	  spectrom	  etry	  for	  identification	  using	  an	  Ultraflex	  III	  MALDI	  TOF/TOF	  instrument	  (Bruker	  Daltonics,	  Bremen).	  The	  spots	  were	  cut	  out	  of	  the	  2-­‐DE,	  destained	  overnight	  with	  a	  4.2	  g/L	  solution	  of	  ammonium	  bicarbonate	  and	  400	  mL/L	  ethanol,	  and	  then	  washed	  3	  times	  for	  10	  min	  with	  acetonitrile	  and	  dried	  in	  a	  Speedvac.	  Proteins	  were	  in	  gel	  digested	  with	  trypsin	  (Promega,	  Madison,	  WI),	  and	  spectra	  were	  acquired	  as	  previously	  described	  (Zava	  et	  al.,	  2009).	  Mascot	  and	  MS-­‐Fit	  software	  packages	  were	  used	  to	  search	  against	  the	  NCBInr.2011.10.10	  database	  using	  the	  peptide-­‐mass	  fingerprinting	  (PMF)	  method	  (Pappin	  et	  al.,	  1993).	  The	  following	  parameters	  were	  set	  for	  the	  searches:	  S-­‐carbamidomethyl	  derivate	  on	  cys	  teine	  as	  fixed	  modification,	  oxidation	  on	  methionine	  as	  variable	  modification,	  and	  2	  missed	  cleavage	  sites	  for	  trypsin	  digestion.	  The	  peptide	  mass	  tolerance	  was	  20	  ppm.	  For	  in	  silico	  analysis,	  the	  Basic	  Local	  Alignment	  Search	  Tool	  (BLAST)	  program	  (Altschul	  et	  al.,	  1990)	  was	  used	  for	  nucleotide	  and	  protein	  homology	  search,	  as	  far	  as	  for	  the	  detection	  of	  tryptophan	  codons.	  
Site-­‐directed	  Polymerase	  Chain	  Reaction-­‐Mediated	  Mutagenesis	  
Mycoplasma	  gallisepticum	  American	  Type	  Culture	  Collection	  (ATCC)	  Strain	  15302	  was	  used	  for	  genomic	  DNA	  extraction.	  A	  single	  tryptophan	  codon	  UGA	  was	  detected	  in	  the	  whole	  E2	  gene	  and	  point-­‐mutated	  to	  convert	  into	  UGG,	  using	  two	  polymerase	  chain	  reaction	  (PCR)	  runs	  as	  described	  (Villarroel	  and	  Regal	  ado,	  1997;	  Rosati	  et	  al.,	  2000).	  Briefly,	  in	  the	  first	  run,	  the	  following	  primer	  sets	  (mutated	  positions	  are	  boxed)	  were	  used	  to	  generate	  2	  overlapping	  fragment	  [offset	  by	  30	  base	  pair	  (bp)]:	  MGfow	  5′	  TTGGATCCTTTGAATATAAATTTACAGACGTTG	  and	  MGmut–	  rev	  5′	  -­‐TTATCAGCACCATCGAT	  CA	  TCTGTGGTCAGCTGC	  for	  the	  amplification	  of	  the	  first	  fragment	  and	  MGmut–	  fow	  5′	  -­‐TTGCAGC	  TGACCACAGAT	  GATCGATGGTGCTGAT	  and	  MGrev	  5′-­‐TTGAATTCAATTAGTAAACCGTTAAGA	  TTTTC	  for	  the	  second	  fragment.	  The	  MGfow	  and	  MGrev	  primers	  contained	  restriction	  sites	  for	  BamHI	  and	  EcoRI,	  respectively	  (underlined	  in	  the	  primer	  sequences),	  to	  facilitate	  the	  following	  cloning	  step.	  Forward	  MGfow	  primer	  was	  designed	  excluding	  the	  protein	  leader	  peptide	  sequence.	  The	  first	  PCR	  reaction	  (50	  μL	  volume)	  contained	  10	  mM	  Tris-­‐HCl,	  pH	  8.8,	  50	  mM	  KCl,	  1.5	  mM	  MgCl2	  ,	  200	  μM	  deoxynucleotide	  triphosphates	  (dNTPs),	  10	  pmol	  each	  primers,	  50	  ng	  of	  template,	  1	  U	  Hotstar	  Taq	  DNA	  polymerase	  (Qiagen,	  Venlo,	  Netherlands).	  PCR	  was	  performed	  in	  7min	  at	  95◦C	  followed	  by	  30	  cycles	  of	  60	  s	  at	  95◦C,	  60	  s	  at	  50◦C,	  and	  60	  s	  at	  72◦C,	  and	  a	  final	  extension	  of	  7min	  at	  72◦C.	  Amplified	  products	  were	  resolved	  and	  visualized	  after	  agarose	  gel	  electrophoresis	  and	  ethidium	  bromide	  staining,	  gel	  purified,	  and	  combined	  in	  equimolar	  concentrations	  to	  form	  the	  template	  for	  the	  second	  PCR	  run,	  using	  the	  most	  external	  primers.	  During	  the	  annealing	  step,	  overlapping	  fragments	  joined	  each	  other	  accomplishing	  the	  full	  length	  synthesis	  of	  the	  gene	  encoding	  the	  mature	  protein.	  The	  second	  reaction	  mixture	  (50μL	  volume)	  contained	  the	  same	  buffer	  as	  above,	  200μM	  dNTPs,	  50pmol	  each	  primer,	  and	  1	  U	  Taq	  polymerase.	  Amplification	  was	  performed	  as	  described	  above	  in	  40	  cycles.	  
Cloning	  and	  Sequencing	  of	  Mutated	  Genes	  Amplified	  product	  of	  the	  expected	  length	  was	  di	  gested	  with	  appropriate	  restriction	  enzymes	  (Thermo	  Scientific,	  Waltham,	  MA),	  purified,	  and	  cloned	  into	  pSER-­‐6HIS	  expression	  vector,	  which	  allows	  expression	  of	  the	  recombinant	  protein	  fused	  to	  a	  6×	  His	  tag	  at	  the	  N-­‐terminus.	  The	  recombinant	  plasmid	  was	  used	  to	  transform	  Escherichia	  coli	  BL21	  (i.e.,	  DE3)	  competent	  cells,	  plated	  on	  Luria–Bertani	  (LB)	  agar	  with	  ampi	  cillin	  (50μg/mL)	  and	  screened	  by	  colony	  PCR,	  using	  primers	  specific	  for	  the	  pSER	  vector	  (Robino	  et	  al.,	  2005).	  Positive	  colonies	  were	  grown	  in	  2mL	  LB	  with	  ampicillin	  (50μg/mL).	  Plasmids	  were	  extracted	  using	  QIAprep	  Spin	  Miniprep	  Kit	  (Qiagen,	  Venlo,	  Nether	  lands)	  and	  sequenced	  in	  order	  to	  confirm	  the	  induced	  point	  mutation	  (BMR	  Genomics,	  Padova,	  Italy).	  
Expression	  and	  Purification	  of	  Recombinant	  Protein	  To	  express	  the	  recombinant	  protein,	  early	  log	  phase	  culture	  [optical	  density	  (OD)600	  =	  0.6]	  of	  a	  positive	  clone	  was	  induced	  for	  2	  h	  with	  0.1mM	  isopropyl	  b	  thiogalactopyranoside	  (IPTG)	  under	  agitation.	  Bacte	  rial	  cells	  were	  recovered	  by	  centrifugation,	  washed	  1×	  with	  PBS,	  and	  lysed	  by	  conventional	  physico-­‐chemical	  methods.	  Soluble	  fractions	  were	  separated	  by	  centrifu	  gation	  and	  sequentially	  extracted	  in	  a	  buffer	  contain	  ing	  20mM	  sodium	  phosphate	  pH	  7.4,	  0.5M	  NaCl,	  10mM	  imidazole,	  and	  increscent	  urea	  concentrations	  (urea	  0	  M	  :	  S0	  fraction;	  urea	  1M:	  S1	  fraction;	  urea	  4M:	  S2	  fraction;	  urea	  8M:	  S3	  fraction).	  Fraction	  analysis,	  carried	  out	  by	  SDS–PAGE,	  re	  vealed	  that	  recombinant	  protein	  was	  located	  in	  the	  S3	  fraction.	  Purification	  was	  conducted	  by	  immobilized	  metal	  chelate	  affinity	  chromatography	  using	  an	  high	  performance	  liquid	  chromatography	  (HPLC)	  system.	  (GE	  Healthcare,	  Little	  Chalfont,	  UK)	  under	  denatur	  ing	  condition	  (Smith	  and	  Johnson,	  1988).	  Purity	  of	  each	  fraction	  of	  eluted	  protein	  was	  analyzed	  by	  SDS–PAGE	  and	  protein	  concentration	  estimated	  by	  a	  DC	  protein	  assay	  (BioRad,	  Hercules,	  CA).	  
Western	  Blot	  Analysis	  
To	  confirm	  the	  presence	  and	  the	  molecular	  mass	  of	  the	  recombinant	  proteins,	  Western	  blotting	  was	  car	  ried	  out	  using	  an	  anti-­‐6×	  His	  monoclonal	  antibody	  as	  probe.	  Purified	  recombinant	  proteins	  were	  sepa	  rated	  by	  10%	  SDS–PAGE,	  transferred	  to	  a	  nitrocellu	  lose	  membrane,	  and	  subsequently	  blocked	  with	  5%	  non	  fat	  powdered	  milk	  in	  PBS	  for	  2h.	  After	  washing	  with	  PBS-­‐Tween	  0.05%,	  the	  membrane	  was	  incubated	  with	  anti-­‐6×	  His	  monoclonal	  antibody	  (GE	  Healthcare,	  Lit	  tle	  Chalfont,	  UK)	  for	  1	  h	  at	  room	  temperature.	  After	  a	  second	  washing	  step,	  the	  membrane	  was	  incubated	  with	  horseradish	  peroxidase	  (HRP)-­‐conjugate	  anti-­‐mouse	  IgG	  (KPL	  Laboratories,	  Gaithersburg,	  UMDSA)	  for	  1	  h	  at	  room	  temperature.	  Immunoreactive	  protein	  bands	  were	  stained	  with	  10	  mg	  3,3′-­‐diaminobenzidine	  tetrahy	  drochloride	  (DAB,	  Sigma-­‐Aldrich,	  Milano,	  Italy).	  To	  evaluate	  the	  expression,	  antigenic	  stability,	  and	  specificity	  of	  the	  corresponding	  native	  protein,	  a	  spe	  cific	  rabbit	  antiserum	  was	  elicited	  using	  the	  purified	  recombinant	  antigen	  E2	  as	  an	  immunogen	  (Khiari	  and	  Mardassi,	  2012).	  The	  rabbit	  serum	  was	  probed	  against	  whole	  lysate	  of	  7	  different	  field	  MG	  strains	  as	  well	  as	  different	  avian	  mycoplasmas	  [2	  Mycoplasma	  syn	  oviae	  (MS)	  and	  1	  Mycoplasma	  iowae	  (MI)	  samples].	  All	  samples	  are	  field	  isolates	  that	  were	  identified	  and	  characterized	  by	  denaturing	  gradient	  gel	  electrophore	  sis	  (DGGE)	  PCR	  in	  our	  laboratory.	  
Serum	  Samples	  and	  ELISA	  Procedure	  For	  the	  evaluation	  of	  the	  developed	  ELISA	  protocol	  12	  serum	  samples	  were	  collected	  from	  naturally	  MG	  infected	  chickens	  flocks	  (confirmed	  by	  PCR	  and	  bacte	  rial	  isolation)	  and	  32	  from	  specific-­‐pathogen-­‐free	  (SPF)	  subjects.	  ELISA	  was	  carried	  out	  as	  previously	  described	  with	  minor	  modifications	  (Rosati	  et	  al.,	  2000),	  using	  a	  commercially	  available	  monospecific	  MG	  antiserum	  (Biovac,	  Beaucouz	  ́e,	  France)	  as	  positive	  control	  and	  a	  SPF	  serum	  as	  negative	  control.	  Briefly,	  microplate	  was	  coated	  with	  100	  ng/well	  of	  re	  combinant	  antigen.	  Serum	  samples,	  diluted	  1/10	  were	  incubated,	  in	  duplicate,	  for	  1h	  at	  room	  temperature.	  After	  3	  washing	  steps,	  100	  of	  anti-­‐chicken	  IgY	  (Sigma	  Aldrich,	  Milano,	  Italy)	  was	  added	  to	  each	  well	  and	  plate	  incubated	  as	  above.	  Following	  the	  final	  washing	  steps,	  reactions	  were	  developed	  with	  2,20-­‐azino-­‐bis-­‐[3	  ethylbenzthiazoline-­‐6-­‐sulfonic	  acid	  (ABTS,	  Chemicon,	  Temecuta,	  CA)]	  and	  read	  at	  405	  nm.	  Absorbance	  was	  expressed	  as	  percentage	  of	  reactivity	  of	  the	  positive	  con	  trol	  serum.	  Sera	  with	  reactivity	  >	  40%	  of	  the	  positive	  control	  serum	  were	  classified	  as	  positive.	  Differences	  be	  tween	  absorbance	  in	  negative	  and	  positive	  sera	  were	  tested	  by	  nonparametric	  statistics	  (Wilcoxon	  2-­‐sample	  test)	  using	  R	  software	  (R	  Core	  Team,	  2013).	  
RESULTS	  
Two-­‐Dimensional	  Gel	  Electrophoresis	  and	  Mass	  Spectrometry	  Analysis	  and	  Protein	  
Identification	  Following	  fractionation	  of	  total	  cell	  lysate	  and	  2-­‐DE,	  a	  companion	  gel	  was	  electro	  blotted	  on	  membrane	  and	  immunostained	  with	  reference	  MG	  positive	  sera.	  Two	  major	  spots	  were	  recognized	  (Figure	  1)	  and	  analyzed	  by	  MALDI–TOF/TOF.	  Peptide	  mass	  fingerprinting	  re	  sulted	  in	  the	  identification	  of	  pMGA	  and	  E2	  protein	  (a	  total	  of	  3	  peptides	  recognized	  in	  a	  total	  of	  27	  with	  a	  coverage	  of	  11%).	  Since	  pMGA	  is	  already	  a	  well-­‐known	  protein,	  with	  a	  large	  potential	  for	  generation	  of	  anti	  genic	  variants	  (Bencina,	  2002),	  we	  decided	  to	  further	  characterize	  only	  the	  E2	  protein.	  
Recombinant	  E2	  Expression	  The	  complete	  gene	  of	  E2,	  lacking	  the	  most	  5′	  ter	  minal	  region	  corresponding	  to	  the	  leader	  peptide,	  was	  then	  retrieved	  from	  the	  database	  Genbank	  amplified	  in	  2	  different	  PCR	  runs	  to	  accomplish	  site-­‐directed	  muta	  genesis	  to	  convert	  a	  single	  TGA	  codon	  into	  TGG	  and	  allow	  expression	  of	  full	  product	  in	  EC.	  As	  expected,	  af	  ter	  the	  second	  PCR	  run	  a	  single	  band	  of	  1.3	  kb	  was	  detected.	  The	  amplicon	  was	  cloned	  into	  pSER-­‐6HIS	  plasmid	  and	  sequence	  analysis	  
conducted	  with	  vector	  primers	  confirmed	  that	  mutagenesis	  was	  truly	  accom	  plished	  and	  the	  E2	  amplicon	  was	  cloned	  in	  the	  correct	  frame	  and	  orientation.	  When	  positive	  clone	  was	  grown	  and	  induced,	  a	  new	  protein	  band	  was	  clearly	  detected	  in	  SDS–PAGE	  with	  an	  apparent	  molecular	  weight	  of	  49	  kDa,	  corresponding	  to	  E2	  protein.	  The	  recombinant	  E2	  fusion	  protein	  was	  found	  to	  be	  soluble	  in	  8M	  urea	  and	  purified	  under	  denatured	  condition.	  
Western	  Blot	  and	  ELISA	  Analyses	  The	  purified	  recombinant	  protein	  was	  immunos	  tained	  in	  Western	  Blot	  using	  an	  anti-­‐6×	  His	  MAb	  which	  probes	  the	  C′	  terminal	  tag	  of	  fusion	  protein.	  The	  purified	  recombinant	  protein	  was	  used	  as	  immunogen	  to	  elicit	  a	  specific	  immunoresponse	  in	  rabbit	  and	  the	  monospecific	  serum	  was	  used	  in	  a	  second	  Western	  Blot	  experiments	  using	  total	  cell	  lysates	  of	  different	  avian	  mycoplasmas.	  The	  antiserum	  was	  able	  to	  recognize	  the	  native	  protein	  with	  the	  expected	  molecular	  weight	  in	  all	  MG	  samples	  tested;	  meanwhile	  no	  reaction	  was	  ob	  served	  in	  the	  MS	  and	  MI	  control	  samples	  (Figure	  2).	  	  Recombinant	  E2	  was	  tested	  in	  ELISA	  at	  the	  opti	  mal	  conditions	  described	  above.	  A	  panel	  including	  12	  positive	  and	  32	  negative	  samples	  was	  tested.	  Results	  showed	  a	  significant	  difference	  between	  OD	  recorded	  in	  the	  2	  groups.	  In	  more	  details,	  all	  positive	  sera	  tested	  positive	  in	  ELISA;	  among	  negative	  samples,	  3	  sera	  were	  erroneously	  classified	  as	  positive,	  showing	  low	  OD	  val	  ues.	  Differences	  between	  OD	  values	  of	  sera	  belonging	  to	  positive	  and	  negative	  sample	  sets	  were	  statistically	  significant	  as	  expected	  (Wilcoxon	  rank	  sum	  test	  P	  <	  0.001).	  A	  boxplot	  of	  ELISA	  OD	  values	  obtained	  by	  r	  E2	  ELISA	  is	  shown	  in	  Figure	  3.	  
	  
DISCUSSION	  The	  identification	  and	  characterization	  of	  novel	  immunogenic	  proteins	  are	  important	  for	  the	  development	  of	  both	  improved	  diagnostic	  assays	  and	  subunit	  vac	  cines.	  In	  order	  to	  reach	  new	  and	  useful	  results	  in	  this	  research	  field,	  the	  2-­‐DE	  is	  a	  technique	  that	  can	  be	  routinely	  applied	  for	  parallel	  quantitative	  expression	  pro	  filing	  of	  large	  sets	  of	  complex	  protein	  mixtures.	  This	  technique	  is	  able	  to	  detect	  and	  characterize	  immunodominant	  proteins,	  and	  it	  was	  used	  to	  improve	  the	  knowledge	  about	  MG	  proteins	  as	  potential	  candidates	  for	  the	  diagnosis	  and	  control	  of	  infections	  (Go	  ̈rg	  et	  al.,	  2004).	  The	  pMGA	  gene	  family	  is	  a	  large	  group	  of	  surface	  proteins	  mediating	  the	  phase	  variation	  of	  the	  bacterial	  surface	  architecture	  and	  they	  are	  believed	  to	  be	  involved	  in	  evasion	  of	  the	  host	  immune	  system	  (Glew	  et	  al.,	  2000;	  Bearson	  et	  al.,	  2003;	  Szczepanek	  et	  al.,	  2010).	  Metabolic	  pathways	  have	  also	  been	  shown	  to	  contribute	  to	  MG	  virulence	  and	  host-­‐interaction	  and,	  in	  our	  study,	  a	  com	  ponent	  of	  the	  pyruvate	  dehydrogenase	  was	  identified	  by	  2-­‐DE	  analysis,	  the	  dihydrolipoamide	  acetyltransferase	  (i.e.,	  E2).	  This	  protein	  was	  first	  described	  by	  Jan	  and	  colleagues	  in	  1996	  and	  fully	  sequenced	  by	  Szczepanek	  and	  colleagues	  in	  2010.	  E2	  was	  proven	  to	  be	  highly	  im	  munogenic	  and	  antibodies	  directed	  against	  it	  induced	  growth	  inhibition	  of	  cells	  and	  activation	  of	  the	  comple	  ment	  system.	  Moreover,	  topological	  experiments	  using	  in	  situ	  treatment	  with	  proteases	  and	  growth	  inhibition	  in	  the	  presence	  of	  anti-­‐E2	  serum	  provided	  evidence	  of	  the	  surface	  exposition	  of	  the	  polypeptide	  (Jan	  et	  al.,	  1996),	  but	  to	  our	  knowledge	  no	  serological	  and	  diag	  nostic	  potential	  of	  this	  protein	  was	  not	  yet	  evaluated.	  In	  this	  study,	  with	  the	  aim	  to	  fully	  characterize	  the	  E2,	  we	  directly	  mutagenized	  its	  gene	  and	  successfully	  produced	  recombinant	  protein	  in	  a	  prokaryotic	  sys	  tem.	  The	  results	  obtained	  after	  the	  Western	  Blot	  using	  the	  E2	  rabbit	  antiserum	  with	  different	  strains	  of	  my	  coplasmas	  showed	  that	  E2	  protein	  is	  stably	  expressed	  in	  all	  MG	  tested	  strains	  isolated	  in	  different	  parts	  of	  Italy,	  while	  no	  cross	  reaction	  was	  found	  in	  any	  MS	  and	  MI	  strains	  tested.	  This	  aspect	  is	  particularly	  impor	  tant	  given	  that	  MG	  is	  equally	  pathogenic	  for	  poultry	  compared	  to	  MS	  and	  MI,	  causing	  important	  economic	  losses.	  Under	  the	  diagnostic	  point	  of	  view	  it	  is	  funda	  mental	  to	  overcome	  the	  possibility	  of	  cross	  reactions	  in	  serological	  tests,	  especially	  in	  field	  samples.	  These	  results	  also	  agree	  with	  the	  ones	  found	  by	  Jan	  and	  coau	  thors	  in	  2001.	  Indeed	  the	  anti-­‐
E2	  serum	  revealed	  a	  polypeptide	  with	  an	  apparent	  molecular	  mass	  close	  to	  52	  kDa	  in	  all	  of	  the	  MG	  strains	  assayed,	  demonstrating	  the	  antigenic	  stability	  of	  the	  protein	  and	  reinforcing	  the	  idea	  that	  it	  might	  be	  used	  to	  develop	  serologic	  diagnostic	  tests	  based	  on	  the	  detection	  of	  anti-­‐E2	  antibodies	  in	  infected	  hosts.	  In	  the	  ELISA	  test,	  r-­‐E2	  was	  capable	  of	  detecting	  all	  the	  positive	  serum	  tested,	  even	  though	  there	  were	  some	  showing	  low	  OD	  values,	  slightly	  above	  the	  cutoff.	  The	  presence	  of	  3	  false-­‐positive	  results	  among	  negative	  samples	  revealed	  a	  nonabsolute	  specificity	  of	  the	  test.	  It	  is	  known	  that	  many	  parameters	  are	  involved	  in	  stimulating	  the	  avian	  immune	  system	  and	  the	  obtained	  results	  can	  be	  explained	  by	  the	  variation	  of	  the	  immune	  response	  of	  the	  host,	  according	  to	  individual	  response	  to	  infection	  and	  heterogeneity	  of	  the	  antigen	  presentation	  by	  the	  MG	  (Levisohn	  et	  al.,	  1995;	  Grodio	  et	  al.,	  2012).	  Moreover,	  Western	  Blot	  supports	  the	  specificity	  of	  the	  E2	  against	  sera	  positive	  for	  other	  than	  MG	  mycoplasma	  strains.	  Given	  this,	  our	  results	  seem	  to	  suggest	  that	  the	  false	  positive	  outcomes	  could	  be	  justified	  by	  a	  non	  ideal	  ELISA	  test	  optimization.	  Further	  investigations	  about	  serum	  dilution	  and	  conjugate	  concentration	  will	  be	  per	  formed	  in	  order	  to	  obtain	  higher	  signal-­‐to-­‐noise	  ratio	  and,	  consequently,	  better	  diagnostic	  performances.	  In	  conclusion,	  the	  protein	  identified	  by	  the	  2-­‐DE	  analysis	  was	  successfully	  mutagenized	  demonstrating	  that	  the	  used	  method	  is	  fast	  and	  highly	  efficient.	  Over	  all,	  E2	  can	  represent	  a	  recombinant	  antigen	  with	  poten	  tial	  diagnostic	  applications,	  being	  discriminative,	  cost	  effective,	  and	  less	  time-­‐consuming.	  Moreover,	  E2	  can	  improve	  diagnostic	  tools	  together	  with	  the	  well-­‐known	  pMGA	  and	  pvpA	  antigens,	  increasing	  the	  spectrum	  of	  MG	  antibodies	  detected	  in	  serological	  procedures	  and	  representing	  an	  important	  update	  in	  the	  diagnostic	  of	  mycoplasma	  infection	  in	  poultry.	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metal chelate affinity chromatography using an high-
performance liquid chromatography (HPLC) system.
(GE Healthcare, Little Chalfont, UK) under denatur-
ing condition (Smith and Johnson, 1988). Purity of each
fraction of eluted protein was analyzed by SDS–PAGE
and protein concentration estimated by a DC protein
assay (BioRad, Hercules, CA).
Western Blot Analysis
To confirm the presence and the molecular mass of
the recombinant proteins, Western blotting was car-
ried out using an anti-6× His monoclonal antibody
as probe. Purified recombinant proteins were sepa-
rated by 10% SDS–PAGE, transferred to a nitrocellu-
lose membrane, and subsequently blocked with 5% non-
fat powdered milk in PBS for 2 h. After washing with
PBS-Tween 0.05%, the membrane was incubated with
anti-6× His monoclonal antibody (GE Healthcare, Lit-
tle Chalfont, UK) for 1 h at room temperature. After a
second washing step, the membrane was incubated with
horseradish peroxidase (HRP)-conjugate anti-mouse
IgG (KPL Laboratories, Gaithersburg, UMDSA) for 1 h
at room temperature. Immunoreactive protein bands
were stained with 10 mg 3,3′-diaminobenzidine tetrahy-
drochloride (DAB, Sigma-Aldrich, Milano, Italy).
To evaluate the expression, antigenic stability, and
specificity of the corresponding native protein, a spe-
cific rabbit antiserum was elicited using the purified
recombinant antigen E2 as an immunogen (Khiari and
Mardassi, 2012). The rabbit serum was probed against
whole lysate of 7 different field MG strains as well
as different avian mycoplasmas [2 Mycoplasma syn-
oviae (MS) and 1 Mycoplasma iowae (MI) samples].
All samples are field isolates that were identified and
characterized by denaturing gradient gel electrophore-
sis (DGGE) PCR in our laboratory.
Serum Samples and ELISA Procedure
For the evaluation of the developed ELISA protocol
12 serum samples were collected from naturally MG-
infected chickens flocks (confirmed by PCR and bacte-
rial isolation) and 32 from specific-pathogen-free (SPF)
subjects. ELISA was carried out as previously described
with minor modifications (Rosati et al., 2000), using
a commercially available monospecific MG antiserum
(Biovac, Beaucouze´, France) as positive control and a
SPF serum as negative control.
Briefly, microplate was coated with 100 ng/well of re-
combinant antigen. Serum samples, diluted 1/10 were
incubated, in duplicate, for 1 h at room temperature.
After 3 washing steps, 100 of anti-chicken IgY (Sigma-
Aldrich, Milano, Italy) was added to each well and
plate incubated as above. Following the final washing
steps, reactions were developed with 2,20-azino-bis-[3-
ethylbenzthiazoline-6-sulfonic acid (ABTS, Chemicon,
Temecuta, CA)] and read at 405 nm. Absorbance was
expressed as percentage of reactivity of the positive con-
trol serum. Sera with reactivity > 40% of the positive
control serum were classified as positive. Differences be-
tween absorbance in negative and positive sera were
tested by nonparametric statistics (Wilcoxon 2-sample
test) using R software (R Core Team, 2013).
RESULTS
Two-Dimensional Gel Electrophoresis
and Mass Spectrometry Analysis
and Protein Identification
Following fractionation of total cell lysate and 2-DE,
a companion gel was electro blotted on membrane and
immunostained with reference MG positive sera. Two
major spots were recognized (Figure 1) and analyzed
by MALDI–TOF/TOF. Peptide mass fingerprinting re-
sulted in the identification of pMGA and E2 protein
Figure 1. 2D gel electrophoresis and Western blot of Mycoplasma
gallisepticum total proteins. MG proteins were separated on pH 4 to 7
linear strips and 10% acrylamide gels followed by (A) Coomassie stain-
ing, (B) silver staining (B), and (C) immunoblotting using monospe-
cific serum. Proteins in the molecular mass standard are indicated to
the right of the gels. Spot position of the E2 protein is indicated by
white arrow.
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(a total of 3 peptides recognized in a total of 27 with a
coverage of 11%). Since pMGA is already a well-known
protein, with a large potential for generation of anti-
genic variants (Bencina, 2002), we decided to further
characterize only the E2 protein.
Recombinant E2 Expression
The complete gene of E2, lacking the most 5′ ter-
minal region corresponding to the leader peptide, was
then retrieved from the database Genbank amplified in
2 different PCR runs to accomplish site-directed muta-
genesis to convert a single TGA codon into TGG and
allow expression of full product in EC. As expected, af-
ter the second PCR run a single band of 1.3 kb was
detected. The amplicon was cloned into pSER-6HIS
plasmid and sequence analysis conducted with vector
primers confirmed that mutagenesis was truly accom-
plished and the E2 amplicon was cloned in the correct
frame and orientation. When positive clone was grown
and induced, a new protein band was clearly detected
in SDS–PAGE with an apparent molecular weight of
49 kDa, corresponding to E2 protein. The recombinant
E2 fusion protein was found to be soluble in 8M urea
and purified under denatured condition.
Western Blot and ELISA Analyses
The purified recombinant protein was immunos-
tained in Western Blot using an anti-6× His MAb
which probes the C′ terminal tag of fusion protein. The
purified recombinant protein was used as immunogen
to elicit a specific immunoresponse in rabbit and the
monospecific serum was used in a second Western Blot
experiments using total cell lysates of different avian
mycoplasmas. The antiserum was able to recognize the
native protein with the expected molecular weight in
all MG samples tested; meanwhile no reaction was ob-
served in the MS and MI control samples (Figure 2).
Figure 3. Distributions of D-values in ELISA test. OD values are
reported as percentage of reactivity of the positive control serum.
Recombinant E2 was tested in ELISA at the opti-
mal conditions described above. A panel including 12
positive and 32 negative samples was tested. Results
showed a significant difference between OD recorded
in the 2 groups. In more details, all positive sera tested
positive in ELISA; among negative samples, 3 sera were
erroneously classified as positive, showing low OD val-
ues. Differences between OD values of sera belonging
to positive and negative sample sets were statistically
significant as expected (Wilcoxon rank sum test P <
0.001). A boxplot of ELISA OD values obtained by r-
E2 ELISA is shown in Figure 3.
DISCUSSION
The identification and characterization of novel im-
munogenic proteins are important for the development
of both improved diagnostic assays and subunit vac-
cines. In order to reach new and useful results in this
research field, the 2-DE is a technique that can be rou-
tinely applied for parallel quantitative expression pro-
filing of large sets of complex protein mixtures. This
Figure 2. Western Blot using the E2 rabbit antiserum. Lanes M: molecular weight marker; Lanes 1 and 7: r-E2 (positive control); Lanes 2
to 6, 8, and 9: whole lysate of different field Mycoplasma gallisepticum strains; Lanes 10 and 11: whole lysate of different Mycoplasma synoviae
strains; Lane 12: whole lysate of Mycoplasma iowae; Lane 13: negative control.
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